Open-Label Extension of Zilucoplan in Subjects With Generalized Myasthenia Gravis

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

December 23, 2019

Primary Completion Date

June 2, 2026

Study Completion Date

June 2, 2026

Conditions
Generalized Myasthenia Gravis
Interventions
DRUG

zilucoplan (RA101495)

Daily subcutaneous (SC) injection

Trial Locations (70)

10021

Mg0011 23, New York

10029

Mg0011 47, New York

11021

Mg0011 123, Great Neck

15212

Mg0011 40, Pittsburgh

20052

Mg0011 27, Washington D.C.

22903

Mg0011 164, Charlottesville

27599

Mg0011 22, Chapel Hill

30912

Mg0011 135, Augusta

33612

Mg0011 25, Tampa

36604

Mg0011 41, Mobile

38018

Mg0011 28, Cordova

43210

Mg0011 38, Columbus

44195

Mg0011 122, Cleveland

46202

Mg0011 156, Indianapolis

48201

Mg0011 33, Detroit

48824

Mg0011 49, East Lansing

53215

Mg0011 45, Milwaukee

65201

Mg0011 134, Columbia

66160

Mg0011 32, Kansas City

75390

Mg0011 19, Dallas

78759

Mg0011 131, Austin

84105

Mg0011 39, Salt Lake City

85028

Mg0011 116, Phoenix

89145

Mg0011 117, Las Vegas

90033

MG0011 4, Los Angeles

91101

Mg0011 220, Pasadena

92697

Mg0011 31, Irvine

94115

Mg0011 160, San Francisco

98195

Mg0011 154, Seattle

06511

Mg0011 24, New Haven

60026-1339

Mg0011 188, Glenview

14202-1102

Mg0011 30, Buffalo

29425-8908

Mg0011 128, Charleston

Unknown

Mg0011 11, Montreal

Mg0011 204, Lille

Mg0011 118, Nice

Mg0011 105, Paris

Mg0011 137, Strasbourg

Mg0011 150, Göttingen

Mg0011 129, Tübingen

Mg0011 132, Milan

Mg0011 126, Roma

Mg0011 151, Chiba

Mg0011 136, Hanamaki-shi

Mg0011 179, Kita-gun

Mg0011 153, Meguro-ku

Mg0011 146, Nagasaki

Mg0011 169, Narita

Mg0011 152, Sapporo

Mg0011 144, Sendai

Mg0011 163, Shinjuku-ku

Mg0011 141, Tokyo

Mg0011 140, Bergen

Mg0011 143, Oslo

Mg0011 195, Katowice

Mg0011 213, Katowice

Mg0011 192, Krakow

Mg0011 193, Krakow

Mg0011 211, Krakow

Mg0011 214, Lodz

Mg0011 205, Lublin

Mg0011 194, Nowa Sól

Mg0011 209, Poznan

Mg0011 201, Warsaw

Mg0011 210, Zabrze

Mg0011 133, Barcelona

Mg0011 168, Barcelona

Mg0011 138, Bilbao

Mg0011 119, Oxford

Mg0011 130, Sheffield

All Listed Sponsors
lead

UCB Biopharma SRL

INDUSTRY